Kokul Wimalanathan

Applying bioinformatics at Atalanta Therapeutics for treating patients with neurodegenerative disorders. He/him. RT doesn't mean endorsement.

[AtalantaTx @AtalantaTx]

Today, on Huntington’s Disease Awareness Day, we stand in solidarity with the global HD community.
At Atalanta, we are dedicated to advancing scientific understanding and developing meaningful treatments that support individuals and families affected by Huntington’s disease—a rare, inherited neurodegenerative disorder that affects thousands of families worldwide.​
We honor the individuals, caregivers, and advocates impacted by HD, who inspire us every day. #LetsTalkAboutHD #AtalantaTX

[AtalantaTx @AtalantaTx]

Today, Atalanta celebrates DNA Day, marking the discovery of the double helical structure of DNA in 1953. By “unraveling” the mysteries of DNA, we've been empowered to explore new frontiers in neuroscience, driving Atalanta’s relentless pursuit of therapies to treat neurological disorders with high unmet needs. #DNAday #AtalantaTX

[AtalantaTx @AtalantaTx]

We are proud to announce the publication of our latest preclinical study results in the journal Epilepsia. Our groundbreaking research on KCNT1-related epilepsy demonstrates the potential of ATL-201 to significantly suppress seizures through 6 months. This study highlights our commitment to pioneering innovative treatments for severe neurological disorders and brings us one step closer to transforming the lives of people impacted by KCNT1 epilepsy. Read more about our findings here: https://t.co/uchnb4trM8
#AtalantaTX

[AtalantaTx @AtalantaTx]

We glided across the ice for a great cause! Atalanta Therapeutics was proud to sponsor and participate in the Curling for Cure event at Broomstones Curling Club, supporting research for Huntington's Disease. We remain committed to advancing potential therapies for Huntington's and other neurological disorders. A huge thank you to the @hdsa_mari chapter for their incredible work! #AtalantaTX #HDSA

[AtalantaTx @AtalantaTx]

February 28th is Rare Disease Day, recognizing the millions of individuals around the world who are impacted by a rare disease. Yesterday, we joined the Rare Disease Day Walk in the Seaport with our biotech colleagues. It was inspiring to see everyone come together, donning their zebra stripes, to raise awareness and show support for those affected by rare diseases. The zebra stripes symbolize the uniqueness and rarity of these conditions. Together, we are committed to making significant strides in the ongoing fight against rare diseases, ensuring no one faces these challenges alone. #RareDiseaseDay #ShowYourStripes #TogetherWeCan

[Molly White @molly0xFFF]

VSCode is free software. It's not even possible to buy a license for it.

[AtalantaTx @AtalantaTx]

We are excited to share that our President and CEO, Alicia Secor, will be presenting at BioCapital Europe 2025 on February 6th at 12pm CET. Join us to learn more about Atalanta Therapeutics innovative pipeline and our mission to pioneer new treatment options for CNS diseases with our di-siRNA platform. #BioCapital2025 #AtalantaTX

[AtalantaTx @AtalantaTx]

Bruno Godinho delivered a presentation on the cutting-edge role of di-siRNAs in neurodegenerative disease at the 6th Annual CNS Drug Delivery Summit in Boston. His talk offered a unique perspective on how RNA-based therapies can revolutionize the treatment landscape for neurodegenerative conditions and bring new hope for patients suffering from these debilitating diseases.
#AtalantaTX #CNSDrugDiscoverySummit

[Kokul Wimalanathan @bioinformapping]

Go team! Thrilled to reveal the target and disease area we've been dedicated to for the past few years. This therapeutic aims to address a significant unmet need for patients with KCNT1-mediated epilepsy.

[AtalantaTx @AtalantaTx]

Ben Andreone, Ph.D. and Jennifer M. Lin, Ph.D. recently presented a poster at AES highlighting our latest data on our ATL-201 program for KCNT1-mediated epilepsy demonstrating that it effectively and durably suppresses or eliminates seizures in a mouse model of KCNT1-related epilepsy. A link to the poster can be found here: https://t.co/86Ih88bg6q
#AES #AtalantaTX

[AtalantaTx @AtalantaTx]

Over 50 million people around the world are affected by epilepsy. At Atalanta, we celebrate the strength and resilience of those impacted by epilepsy and we are committed to advancing research that will lead to potential groundbreaking therapies. #NEAM2024 #ShareYourPurplePower

[Heng Li @lh3lh3]

Students, join the webinar if you are interested in the Harvard BIG PhD program.

[MaizeGDB @MaizeGDB]

(1/3) Our new preprint in collaboration with @jrossibarra and @mbhufford on a unified VCF data set from WGS data from nearly 1,500 diverse with a new version of SNPVersity to query and visualize the data is now available. https://t.co/xBfjaQTvXK

[Kokul Wimalanathan @bioinformapping]

@SOPHiAGENETICS who would be the best person to contact to obtain an official employment certificate?

[Kokul Wimalanathan @bioinformapping]

Such a loss for digital photography enthusiasts. DPReview will be shut down next month. https://t.co/bwgCehuI7H

[Kokul Wimalanathan @bioinformapping]

Could someone recommend a good software to evaluate PacBio Sequel and Sequel II sequencing quality? @PacBio #longreads

[AtalantaTx @AtalantaTx]

Dan and Sheila Kieran joined the Atalanta Team last week to talk about their journey with Huntington’s Disease. Their stories inspired us as we continue our journey to help those affected by neurodegenerative diseases and CNS disorders. #AtalantaTX #DansHDDestroyers

[AtalantaTx @AtalantaTx]

Our Head of Neuroscience, Stefan McDonough, PhD presented at the Stone Zander Translational Neuroscience Center Symposium beside @FPrimeCapital board member Stacie Weninger PhD & other thought leaders introducing our proprietary branched siRNA platform. https://t.co/anIQusEdLN

[Kokul Wimalanathan @bioinformapping]

@IAcornflake @hendrixcollege Congratulations Carolyn..

[AtalantaTx @AtalantaTx]

Here at Atalanta we value the importance of work-life balance. Here are a few pictures our crew took on their journeys. #ArgonautsSetSail #AtalantaTX

[AtalantaTx @AtalantaTx]

Warm welcome to the first half of 2022 Newest Argonauts! We’re lucky to have you join our quest in pioneering treatments for neurodegenerative diseases. Our team continues to grow! If you’re interested in joining our crew visit - https://t.co/0TvNpgDXZU
#AtalantaTX #NewHires